Novo Nordisk A/s Class B · OMXCOP:NOVO_B

Novo Nordisk A/s Class B — Fact Sheet (November 2022)

2 slides from Novo Nordisk A/s Class B's fact sheet, November 2022

  1. Slide 1: What is obesity? The burden of obesity

    What is Prevention Accelerator Worldwide, 650 million obesity? adults live with 975 million obesity 1 adults will live with obesity in 2030 1 124 million Be a part of the change children living with obesity Predicted globally1 to rise to 250 million by 20302 Obesity is commonly measured using body m

  2. Slide 2: Prevention Accelerator

    Obesity is a multifactorial disease, but there remains an underlying Prevention Accelerator societal belief that obesity is a result of lack of willpower, which can For more information on obesity and Novo Nordisk’s lead to people with obesity being subjected to blame and stigma in commitment to dri

Novo Nordisk — Fact Sheet (November 2022) on 6ix